BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 6419599)

  • 1. Early experiences with auranofin in juvenile rheumatoid arthritis.
    Brewer EJ; Giannini EH; Person DA
    Am J Med; 1983 Dec; 75(6A):152-6. PubMed ID: 6419599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Auranofin in the treatment of juvenile rheumatoid arthritis.
    Giannini EH; Brewer EJ; Person DA
    J Pediatr; 1983 Jan; 102(1):138-41. PubMed ID: 6401327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Auranofin in juvenile rheumatoid arthritis. An open label, non-controlled study.
    Garcia-Morteo O; Suarez-Almazor ME; Maldonado-Cocco JA; Cuttica R; Abate S
    Clin Rheumatol; 1984 Jun; 3(2):223-7. PubMed ID: 6432407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood gold concentrations in children with juvenile rheumatoid arthritis undergoing long-term oral gold therapy.
    Giannini EH; Brewer EJ; Person DA
    Ann Rheum Dis; 1984 Apr; 43(2):228-31. PubMed ID: 6424588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Auranofin versus placebo in the treatment of rheumatoid arthritis.
    Wenger ME; Alexander S; Bland JH; Blechman WJ
    Am J Med; 1983 Dec; 75(6A):123-7. PubMed ID: 6419593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood and serum concentrations of gold after a single dose of auranofin in children with juvenile rheumatoid arthritis.
    Giannini EH; Person DA; Brewer EJ; Parks DB
    J Rheumatol; 1983 Jun; 10(3):496-8. PubMed ID: 6411921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral gold (auranofin) in juvenile rheumatoid arthritis: a 48-week phase II study.
    Kvien TK; Høyeraal HM; Sandstad B; Kåss E
    Clin Rheumatol; 1984 Dec; 3(4):551-2. PubMed ID: 6441669
    [No Abstract]   [Full Text] [Related]  

  • 8. Gold in rheumatoid arthritis therapy today. Paediatrics.
    Svantesson H
    Scand J Rheumatol Suppl; 1983; 51():125-6. PubMed ID: 6426047
    [No Abstract]   [Full Text] [Related]  

  • 9. Changes of immunological parameters during auranofin treatment in children affected with juvenile chronic arthritis.
    Fantini F; Cottafava F; Martini A; Murelli M; Franchini E; D'Errico R; Panzarasa R
    Int J Clin Pharmacol Res; 1986; 6(1):61-7. PubMed ID: 3082775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. Subsets of responses.
    Ward JR; Williams HJ; Boyce E; Egger MJ; Reading JC; Samuelson CO
    Am J Med; 1983 Dec; 75(6A):133-7. PubMed ID: 6419595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of oral and parenteral gold therapy and placebo in the treatment of rheumatoid arthritis.
    Williams HJ; Ward JR
    Scand J Rheumatol Suppl; 1983; 51():92-9. PubMed ID: 6426054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Auranofin: a unique oral chrysotherapeutic agent.
    Blodgett RC; Heuer MA; Pietrusko RG
    Semin Arthritis Rheum; 1984 Feb; 13(3):255-73. PubMed ID: 6427927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An European open multicentre trial with auranofin in rheumatoid arthritis.
    Raeman F; Hanssens F; Delattre M
    Clin Rheumatol; 1984 Mar; 3 Suppl 1():33-8. PubMed ID: 6432411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial.
    Ward JR; Williams HJ; Egger MJ; Reading JC; Boyce E; Altz-Smith M; Samuelson CO; Willkens RF; Solsky MA; Hayes SP
    Arthritis Rheum; 1983 Nov; 26(11):1303-15. PubMed ID: 6416259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 12-month comparative trial of auranofin and D-penicillamine in rheumatoid arthritis.
    Felix-Davies DD; Stewart AM; Wilkinson BR; Bateman JR; Delamere JP
    Am J Med; 1983 Dec; 75(6A):138-41. PubMed ID: 6419596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate.
    Hull RG; Morgan SH; Parke AL; Childs L; Goldman M; Hughes GR
    Int J Clin Pharmacol Res; 1984; 4(6):395-401. PubMed ID: 6442711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longterm experience with oral gold in rheumatoid arthritis and psoriatic arthritis.
    Dequeker J; Verdickt W; Gevers G; Vanschoubroek K
    Clin Rheumatol; 1984 Mar; 3 Suppl 1():67-74. PubMed ID: 6432416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. Cooperative systematic studies of rheumatic diseases.
    Williams HJ; Ward JR; Egger MJ; Reading JC; Samuelson CO; Altz-Smith M; Willkens RW; Solsky MA; Hayes SP; Furst D
    Clin Rheumatol; 1984 Mar; 3 Suppl 1():39-50. PubMed ID: 6432412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An oral gold formulation in rheumatoid arthritis. A 12-month follow-up report.
    Schorn D
    S Afr Med J; 1982 Aug; 62(10):313-6. PubMed ID: 6810477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preliminary results of oral gold treatment with auranofin following lack of success of intramuscular gold therapy].
    Rainer F; Ulreich A
    Wien Klin Wochenschr Suppl; 1984; 156():49-51. PubMed ID: 6442058
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.